Amplifon | AMP - Selling And Administration Expenses

Stock Price
9.52
Daily Change
-0.07 -0.75%
Monthly
7.13%
Yearly
-43.77%
Q2 Forecast
9.28

Amplifon reported EUR0 in Selling and Administration Expenses for its fiscal quarter ending in December of 2023.





Selling And Administration Expenses Change Date
Avanos Medical USD 78.8M 1.2M Dec/2025
Brookdale Senior Living USD 39.19M 4.12B Dec/2025
Cencora USD 1.8B 46.42M Dec/2025
Diasorin EUR 100.15M 18.26M Sep/2025
Encompass Health USD 68.4M 12.3M Dec/2025
Enovis USD 270.44M 6.82M Dec/2025
GE HealthCare Technologies USD 1.11B 145M Dec/2025
OPKO Health USD 50.52M 3.28M Dec/2025
Pediatrix Medical Group USD 65.68M 4.89M Dec/2025
Veradigm USD 27.28M 5.24M Dec/2022
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025